Is the Pentagon ready to confront biological threats?
The DoD plans to increase CBRN training and exercises for the US armed forces. (Photo: USAF)
The interest of China, Russia, Iran and North Korea in biological and chemical weapons alongside issues exposed by the outbreak of COVID-19 have raised questions about whether the US military is prepared to deter this type of threat.
The recently released DoD Biodefense Posture Review (BPR) warns that biological incidents ‘risk undermining DoD’s ability to successfully achieve objectives’ of the National Defense Strategy (NDS).
The paper also noted that ‘developments in biological technology are driving an increase in the scope and diversity of biothreats that DoD could face in the next decade’ and the department ‘must take the threat
Already have an account? Log in
Want to keep reading this article?
More from Defence Notes
-
Taiwan approved for purchase of $11 billion in weapons from US
The US State Department’s approval of a multi-billion-dollar sale of weapons to Taiwan includes tactical mission networks equipment, uncrewed aerial systems, artillery rocket systems and self-propelled howitzers as well as anti-tank guided missiles.
-
US National Security Strategy prioritises advanced military capabilities and national industry
The 2025 NSS has emphasised investment in the US nuclear and air defence inventory and national industry, but it leaves multiple unanswered questions on how the White House will implement this approach.
-
Canada set to look away from its neighbour and across the Atlantic for partners
While non-EU UK struggles to join the Security Action for Europe initiative, which provides loans for defence programmes, Canada has become the first country outside Europe to get access – and did so for a nominal fee.
-
NATO experiments with solutions to integrate networks, AI and uncrewed systems
During the latest edition of the NATO DiBaX, the alliance tested multiple capabilities to inform requirements for future efforts.